Hosted on MSN17m
Brian Thompson's boss: Pharma companies are "really responsible" for drug prices
The CEO of the company whose insurance leader was killed in New York pledged to help fix the health care industry while also ...
Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
Drugmakers hiked prices for hundreds of drugs in early January
January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...
Columbus joins national fight accusing drug manufacturers of inflating insulin prices
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
How a Company Makes Millions Off a Hospital Program Meant to Help the Poor
A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big ...
Crain's Chicago Business20h
Despite $3.5B impairment charge on failed Cerevel drug, AbbVie still sees potential
The schizophrenia drug Emraclidine failed to perform in clinical trials but executives say it can still “play a role.” ...
Wockhardt’s ‘miracle drug’ Zaynich: Can it revive the antibiotics market and the company’s fortunes?
Wockhardt’s experimental drug, Zaynich, has shown impressive results, achieving a 100% cure rate in clinical trials for ...
Drug company job cuts surged last year, and this year is starting with more
The job cuts reflect the normal maturation of companies such as Alameda-based Scribe, which is moving from a preclinical to ...
Impacts1d
Process digitization in the pharmaceutical industry: a lever for productivity and compliance
The pharmaceutical industry operates within one of the most highly regulated environments globally, where precision, ...